Compare care options for Bulimia Nervosa

See what we know about each option. We may not have all options. This page does not pick one for you.

Pick up to 4 care options

You can share this page. You do not need an account.

3 selected

What we found

Each option is for Bulimia Nervosa. Research and local care are different facts.

Cognitive Behavioral Therapy

What it is

We have not added a short description yet.

Why it is on this page

People: NICE guideline populations described in recommendation 1.5

Official guideline documents · checked Sep 21, 2026

Relationship: NICE CBT-ED recommendation for bulimia nervosa

Scope: global

Pointer: /document/recommendation

Open source

Source: Official guideline documents. Checked Sep 21, 2026. Scope: global. Link: https://www.nice.org.uk/guidance/ng69/chapter/recommendations

Research for Bulimia Nervosa

Research suggests benefit in this exact scope

Published Sep 21, 2026 · revision 1

conclusion

NICE says individual eating-disorder-focused CBT can be considered for adults when bulimia-nervosa-focused guided self-help is unacceptable, contraindicated, or ineffective after four weeks. This assessment does not compare every option or determine personal suitability.

Official guideline documents · checked Sep 21, 2026

Relationship: supports bounded conclusion

Scope: global

Pointer: /document/recommendation

Open source

Source: Official guideline documents. Checked Sep 21, 2026. Scope: global. Link: https://www.nice.org.uk/guidance/ng69/chapter/recommendations

Compared with the others: Not directly compared. We show each option’s own research.

See the researchFind care

Sertraline

What it is

We have not added a short description yet.

Why it is on this page

People: outpatients with bulimia nervosa as described by the evidence review

PubMed Central open-access full text · checked Sep 21, 2026

Relationship: small trial of sertraline for bulimia nervosa

Scope: global

Pointer: /document/passage

Open source

Source: PubMed Central open-access full text. Checked Sep 21, 2026. Scope: global. Link: https://www.ncbi.nlm.nih.gov/research/bionlp/RESTful/pmcoa.cgi/BioC_json/PMC2927890/unicode

Research for Bulimia Nervosa

Promising, with important evidence limits

Published Sep 21, 2026 · revision 1

conclusion

An open-access evidence review reports one 12-week placebo-controlled study in outpatients with bulimia nervosa that found fewer binge-eating crises and purging episodes with sertraline; one older study is promising but limited evidence. This assessment does not compare every option or determine personal suitability.

PubMed Central open-access full text · checked Sep 21, 2026

Relationship: supports bounded conclusion

Scope: global

Pointer: /document/passage

Open source

Source: PubMed Central open-access full text. Checked Sep 21, 2026. Scope: global. Link: https://www.ncbi.nlm.nih.gov/research/bionlp/RESTful/pmcoa.cgi/BioC_json/PMC2927890/unicode

Compared with the others: Not directly compared. We show each option’s own research.

See the researchFind care

Fluoxetine

What it is

We have not added a short description yet.

Why it is on this page

People: source-defined study populations

DailyMed fluoxetine hydrochloride label · checked Sep 19, 2026

Relationship: label-reported clinical studies for the Need

Scope: country:US

Pointer: /sections/4

Supporting passage: The effectiveness of fluoxetine for the treatment of bulimia was demonstrated in two 8-week and one 16-week, multicenter, parallel-group studies of adult outpatients meeting DSM-III-R criteria for bulimia.

Open source

Source: DailyMed fluoxetine hydrochloride label. Checked Sep 19, 2026. Scope: country:US. Link: https://dailymed.nlm.nih.gov/dailymed/services/v2/spls/f274f102-67ec-46e7-b248-533be2e3003b.xml

Research for Bulimia Nervosa

Research suggests benefit in this exact scope

Published Sep 20, 2026 · revision 1

conclusion

The retained fluoxetine label reports three multicenter studies for bulimia nervosa; this assessment does not determine personal suitability or compare fluoxetine with every alternative.

DailyMed fluoxetine hydrochloride label · checked Sep 19, 2026

Relationship: supports bounded conclusion

Scope: country:US

Pointer: /sections/4

Supporting passage: The effectiveness of fluoxetine for the treatment of bulimia was demonstrated in two 8-week and one 16-week, multicenter, parallel-group studies of adult outpatients meeting DSM-III-R criteria for bulimia.

Open source

Source: DailyMed fluoxetine hydrochloride label. Checked Sep 19, 2026. Scope: country:US. Link: https://dailymed.nlm.nih.gov/dailymed/services/v2/spls/f274f102-67ec-46e7-b248-533be2e3003b.xml

Compared with the others: Not directly compared. We show each option’s own research.

See the researchFind care

Page link: https://everyoption.org/compare/bulimia-nervosa?treatments=cognitive-behavioral-therapy%2Csertraline%2Cfluoxetine